Edesa Biotech (EDSA) Common Equity (2013 - 2026)
Edesa Biotech's Common Equity came in at $8.81 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 37.7% from $14.13 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Common Equity (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Common Equity was $12.45 million, up 528.5% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
- Going back by fiscal year, Common Equity was $1.98 million in FY2024 (-71.9%), $7.05 million in FY2023 (-24.9%), $9.39 million in FY2022 (-28.1%) and $13.06 million in FY2021 (+96.9%).
- The fiscal Q3 2026 figure represents the lowest quarterly Common Equity since fiscal Q1 2025.
- Year-over-year, Common Equity increased in four of the last seven quarters, with growth averaging 218.0%.
- The fastest year-over-year change in Common Equity over five years came in fiscal Q4 2025 (growth of 528.5%), and the weakest in fiscal Q4 2024 (a decline of 71.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Edesa Biotech | 35.16 Mn | 35.16 Mn | - | 8.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.81 Mn |
| Dec 31, 2025 | 13.95 Mn |
| Sep 30, 2025 | 12.45 Mn |
| Jun 30, 2025 | 14.13 Mn |
| Mar 31, 2025 | 15.54 Mn |
| Dec 31, 2024 | 2.26 Mn |
| Sep 30, 2024 | 1.98 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 5.84 Mn |
| Sep 30, 2023 | 7.05 Mn |
| Jun 30, 2023 | 7.85 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 10.27 Mn |
| Sep 30, 2022 | 9.39 Mn |
| Jun 30, 2022 | 11.84 Mn |
| Mar 31, 2022 | 17.02 Mn |
| Dec 31, 2021 | 10.55 Mn |
| Sep 30, 2021 | 13.06 Mn |
| Jun 30, 2021 | 15.80 Mn |
API Access
Edesa Biotech Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();